Search
Feed aggregator
Bluebird Boasts Nearly 140% Revenue Jump, Still Misses Target
Bluebird Boasts Nearly 140% Revenue Jump, Still Misses Target 5/10/2024
Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch
Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch 5/10/2024
Royalty Pharma Drops $525M for Royalties and Milestones on Sanofi-Licensed MS Therapy
Royalty Pharma Drops $525M for Royalties and Milestones on Sanofi-Licensed MS Therapy 5/10/2024
ASGCT24: Translational Research Powering Potentially Transformative Therapies
ASGCT24: Translational Research Powering Potentially Transformative Therapies 5/10/2024
ASGCT24: Early Trial Results from Freeline, Rocket, Creyon and More
ASGCT24: Early Trial Results from Freeline, Rocket, Creyon and More 5/10/2024
The Next Frontier: Industrializing Cell Therapy Manufacturing
The Next Frontier: Industrializing Cell Therapy Manufacturing 5/10/2024
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study
GLP-1s Like Novo Nordisk’s Ozempic Do Not Increase Thyroid Cancer Risk: Study 4/10/2024
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer 4/10/2024
TORL Targets Hot ADC Space with Oversubscribed $158M Series B-2
TORL Targets Hot ADC Space with Oversubscribed $158M Series B-2 4/10/2024
Birth Control Market Evolves as OTC Opill Hits US Stores
Birth Control Market Evolves as OTC Opill Hits US Stores 4/10/2024
Can $12 Billion Jumpstart Women’s Health?
Can $12 Billion Jumpstart Women’s Health? 4/10/2024
Alphabet Soup: AACR and ACC Dominate Headlines This Week
Alphabet Soup: AACR and ACC Dominate Headlines This Week 4/10/2024
YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial
YS Biopharma’s Rabies Vaccine Outperforms Commercial Competitor in Phase III Trial 4/10/2024
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit 4/10/2024
7 Billion-Dollar Oncology M&As from Q1
7 Billion-Dollar Oncology M&As from Q1 4/10/2024
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That.
The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That. 4/10/2024
Poor Customer Data Management Costs Pharma Companies Money: Report
Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024
AACR 2024: What Cancer Researchers Are Talking About
AACR 2024: What Cancer Researchers Are Talking About 4/10/2024
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC 7/9/2024
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study 7/9/2024
World Pharma News
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders
- A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy
- Common gout drug may reduce risk of heart attack and stroke
- New nasal vaccine has potential to transform respiratory disease prevention
- MIT research finds particles that enhance mRNA delivery could reduce vaccine dosage and costs